Related Experiment Video
Updated: Apr 15, 2026
04:13
Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
7.4K
Caring for older people experiencing agitation
Jane Caroline Pritchard1, Ami Brighty
1Dementia, Northamptonshire Healthcare NHS Foundation Trust, Rushden, England.
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|March 26, 2015
Summary
Agitation in older adults, often linked to dementia and delirium, causes distress and safety concerns. This article explores causes and emphasizes communication and non-pharmaceutical interventions for better care.
Area of Science:
- Gerontology
- Psychiatry
- Healthcare Management
Background:
- Agitation is a prevalent issue in older adults, especially in care homes and hospitals.
- It causes distress, links to adverse health outcomes, and poses safety challenges for caregivers and patients.
- Dementia and delirium are common co-occurring conditions that exacerbate agitation.
Purpose of the Study:
- To examine the underlying causes of agitation in older adults.
- To discuss current best practices for managing agitation.
- To highlight the role of communication and non-pharmaceutical interventions.
Main Methods:
- Literature review on agitation in older adults.
- Analysis of the impact of dementia and delirium on agitation.
- Case study illustrating practical application of interventions.
Main Results:
- Agitation is multifactorial, influenced by cognitive impairment and environmental interactions.
- Effective communication strategies are crucial for de-escalation.
- Non-pharmaceutical interventions show promise in managing agitation.
Conclusions:
- Understanding the triggers of agitation is key to effective management.
- Prioritizing communication and non-pharmaceutical approaches improves patient well-being and safety.
- Integrated care strategies are essential for addressing agitation in older populations.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
368
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
368
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
340
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
340
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:30Cognitive Development During Adulthood
1.3K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.3K
01:47Aggression
30.7K
Humans engage in aggression when they seek to cause harm or pain to another person. Aggression takes two forms depending on one’s motives: hostile or instrumental. Hostile aggression is motivated by feelings of anger with intent to cause pain; a fight in a bar with a stranger is an example of hostile aggression. In contrast, instrumental aggression is motivated by achieving a goal and does not necessarily involve intent to cause pain (Berkowitz, 1993); a contract killer who murders for...
30.7K